Zafgen Obtains $21,000,000 New Funding Round

Feed Type
Link
http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=47ca6874-0599-4fde-901b-d5b5745cfa29&Preview=1
Date
12/4/2012
Company Name
Zafgen
Mailing Address
1 Cambridge Center Cambridge, MA 02142
Company Description
The company is developing novel therapeutics for the treatment of obesity.
Website
http://www.zafgen.com
Transaction Type
Venture Equity
Transaction Amount
$21,000,000
Transaction Round
Undisclosed
Proceeds Purposes
Proceeds from the financing will be used to support the continued development of beloranib, the obesity therapeutic that is currently in phase 2a clinical development.
M&A Terms
Venture Investor
Alta Partners
Venture Investor
Atlas Venture
Venture Investor
Third Rock Ventures